Fundraising Fox

ClavystBio

Venture capital

Seed–Series A · 8 people tracked

Fox Verdict
Sign up to see your fit
Stage
Seed–Series A
Instruments
Equity
Founded
2022
AUM
$220M

Team · 8 people

from the firm's website
Yingmin Wang· Director, Digital Health and MedTech
Anselm Tan· Digital Health and MedTech Lead
Johnny Ng· Assistant Vice President, Therapeutics
Yvonne Koh· Vice President, Therapeutics

Frequently asked questions

What stage does ClavystBio invest at?
ClavystBio invests at the Seed, Series A stages.
What sectors does ClavystBio focus on?
ClavystBio focuses on Biotech, Medical Devices.

Similar investors

Featured in lists